Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Katherine Lee, M.D.

Concepts (118)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystadenocarcinoma, Serous320244801.320 Why?
Ovarian Neoplasms8202449031.120 Why?
Uterine Neoplasms2202414240.870 Why?
Carcinosarcoma120241080.870 Why?
Maytansine12019880.610 Why?
Antineoplastic Combined Chemotherapy Protocols72022118760.460 Why?
Genital Neoplasms, Female120195340.440 Why?
Doxorubicin1202022290.440 Why?
Immunoconjugates120199760.370 Why?
Antineoplastic Agents22023136440.310 Why?
Endometrial Neoplasms3202213810.290 Why?
Isoxazoles320242330.280 Why?
Pyrazines3202412040.210 Why?
Deoxycytidine320248860.210 Why?
Molecular Targeted Therapy2202428230.180 Why?
Drug Resistance, Neoplasm3202053300.180 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb12019100.160 Why?
Folate Receptor 112019410.160 Why?
DNA Polymerase II120191030.150 Why?
Neoplasms, Cystic, Mucinous, and Serous120201950.150 Why?
GPI-Linked Proteins120194720.140 Why?
Phenylurea Compounds120205330.140 Why?
Thromboplastin120192890.140 Why?
CA-125 Antigen120192820.130 Why?
Infusions, Intravenous1202022280.120 Why?
Camptothecin120195990.120 Why?
Drug Synergism1201917570.120 Why?
Quinolines120207690.120 Why?
Polyethylene Glycols1202011890.120 Why?
DNA Replication1202114260.110 Why?
Female1620243965320.110 Why?
Drug Design1201910430.110 Why?
Salvage Therapy1202012740.110 Why?
Hospitalists120172970.110 Why?
Tumor Suppressor Protein p532202029520.110 Why?
Cell Adhesion Molecules1201916120.100 Why?
Drug Administration Schedule1202048530.100 Why?
Membrane Proteins2201978690.100 Why?
Antigens, Neoplasm1201919980.090 Why?
Physicians, Primary Care120176220.090 Why?
Continuity of Patient Care1201710770.090 Why?
Fatigue1201715550.090 Why?
Disease-Free Survival1202068530.080 Why?
Toll-Like Receptor 4120135880.080 Why?
Enterocolitis, Necrotizing120133280.080 Why?
Survival Rate22020128260.080 Why?
Protein Kinase Inhibitors2202456900.080 Why?
Humans1720247668120.080 Why?
Stomach Neoplasms1201914800.080 Why?
Microcirculation1201312820.080 Why?
Dose-Response Relationship, Drug12020107450.070 Why?
High-Throughput Nucleotide Sequencing1202036670.070 Why?
Prognosis32024299590.070 Why?
Pancreatitis1201410870.070 Why?
Immunohistochemistry12020110620.070 Why?
Ligands2202232740.060 Why?
Attitude of Health Personnel1201739270.050 Why?
Randomized Controlled Trials as Topic12020103840.050 Why?
Communication1201739050.050 Why?
Clinical Trials as Topic1201980450.050 Why?
Signal Transduction22019236180.050 Why?
Disease Progression12020136420.050 Why?
Ribose12022630.050 Why?
Diphosphates12022890.050 Why?
Intestinal Mucosa1201330410.050 Why?
Mutation32021302140.050 Why?
Adenocarcinoma1201963590.050 Why?
Pancreatic Neoplasms1201954440.050 Why?
Retinoblastoma Binding Proteins120211010.050 Why?
Patient Readmission1201432830.040 Why?
Phthalazines120223970.040 Why?
DNA Mismatch Repair120224310.040 Why?
Platinum120202190.040 Why?
Omentum120191680.040 Why?
Aged520221713440.030 Why?
Middle Aged620202232670.030 Why?
Treatment Outcome22022652860.030 Why?
Carboplatin120197900.030 Why?
Oncogenes1202112320.030 Why?
Microtubule-Associated Proteins1202010730.030 Why?
Breast Neoplasms12022211620.030 Why?
Receptors, Estrogen1202222520.030 Why?
Hospital Administration120173510.030 Why?
Neoplasm Recurrence, Local2202294070.030 Why?
Phosphatidylinositol 3-Kinases1202228820.030 Why?
Nitrites120131560.030 Why?
Pennsylvania120146150.030 Why?
Nitrates120132590.020 Why?
Receptor, erbB-21202225980.020 Why?
Infant Formula120131920.020 Why?
Paclitaxel1201917280.020 Why?
Sulfones120134470.020 Why?
Nitric Oxide Synthase Type III120137060.020 Why?
Purines120136150.020 Why?
Neoplasms12017223500.020 Why?
Milk, Human120134900.020 Why?
Biopsy1202067790.020 Why?
Animals, Newborn1201326770.020 Why?
Microscopy, Confocal1201319690.020 Why?
Patient Care Team1201725190.020 Why?
Inpatients1201725660.020 Why?
Antibodies, Monoclonal1202292440.020 Why?
Analysis of Variance1201362140.010 Why?
Nitric Oxide1201321400.010 Why?
Predictive Value of Tests12020154250.010 Why?
Population Surveillance1201425940.010 Why?
Piperazines1201325470.010 Why?
Adolescent22020889020.010 Why?
Young Adult22020599390.010 Why?
Adult320202233050.010 Why?
Follow-Up Studies12020393120.010 Why?
Mice, Knockout12013144730.010 Why?
Aged, 80 and over12020595480.010 Why?
Time Factors12014401490.010 Why?
Risk Factors12014748890.000 Why?
Mice12013818980.000 Why?
Animals120131689390.000 Why?
Male120143641540.000 Why?
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (118)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.